Loading...
Target Population: Pediatric primary care providers, neonatologists
Background and Objective: Updates the AAP's 2006 practice guideline and provides recommendations for management, with emphasis on new criteria for palivizumab administration
What's Changed: Emphasis on clinical rather than laboratory assessment, recommendations against most therapeutic interventions, and a reiteration of the more restrictive indications for palivizumab
— Diagnose on the basis of clinical assessment, without the use of laboratory or radiographic studies in low-risk children.
— Treatment and management:
The following therapies are not recommended: albuterol, epinephrine, nebulized hype…